(13:50 GMT) Tango Therapeutics Price Target Raised to $46.00/Share From $42.00 by Canaccord Genuity
Dow Jones Newswires
Tango Therapeutics Is Maintained at Buy by Canaccord Genuity
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:TNGX
- Language
- English